Favorable outcomes following CD34-selected stem cell boost for poor graft function after allogeneic hematopoietic stem cell transplantation-Reference-Cited by-同舟云学术

Favorable outcomes following CD34-selected stem cell boost for poor graft function after allogeneic hematopoietic stem cell transplantation

Published:2023-10-13 Issue:1 Volume:59 Page:134-137
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Al-Ramahi Joe S.,Shahzad Moazzam^ORCID,Nguyen Andrea^ORCID,Li Kevin,Amin Muhammad Kashif^ORCID,Ahmed Nausheen^ORCID,Lutfi Forat,DeJarnette Shaun,Chaudhary Sibgha Gull,Bansal Rajat,Abdelhakim Haitham,Shune Leyla,Abdallah Al-Ola,Singh Anurag K.^ORCID,Abhyankar Sunil H.^ORCID,McGuirk Joseph P.^ORCID,Mushtaq Muhammad Umair^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

https://www.nature.com/articles/s41409-023-02125-x.pdf

Reference12 articles.

1. Copelan EA. Hematopoietic stem-cell transplantation. N. Engl J Med. 2006;354:1813–26. https://doi.org/10.1056/NEJMra052638.

2. Cluzeau T, Lambert J, Raus N, Dessaux K, Absi L, Delbos F, et al. Risk factors and outcome of graft failure after HLA matched and mismatched unrelated donor hematopoietic stem cell transplantation: a study on behalf of SFGM-TC and SFHI. Bone Marrow Transpl. 2016;51:687–91. https://doi.org/10.1038/bmt.2015.351.

3. Zhao Y, Gao F, Shi J, Luo Y, Tan Y, Lai X, et al. Incidence, risk factors, and outcomes of primary poor graft function after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transpl. 2019;25:1898–907. https://doi.org/10.1016/j.bbmt.2019.05.036.

4. Shahzad M, Siddiqui RS, Anwar I, Chaudhary SG, Ali T, Naseem M, et al. Outcomes with CD34-selected stem cell boost for poor graft function after allogeneic hematopoietic stem cell transplantation: a systematic review and meta-analysis. Transpl Cell Ther. 2021;27:877.e1–e8. https://doi.org/10.1016/j.jtct.2021.07.012.

5. Klyuchnikov E, El-Cheikh J, Sputtek A, Lioznov M, Calmels B, Furst S, et al. CD34(+)-selected stem cell boost without further conditioning for poor graft function after allogeneic stem cell transplantation in patients with hematological malignancies. Biol Blood Marrow Transpl. 2014;20:382–6. https://doi.org/10.1016/j.bbmt.2013.11.034.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A boost for poor graft function;Blood Advances;2024-09-10

2. Active infection at the time of CD34+ selected stem cell boost is associated with treatment failure and poor overall survival;Blood Advances;2024-09-10

3. Transfusion Support in Hematopoietic Stem Cell Transplantation: A Contemporary Narrative Review;Clinical Hematology International;2024-03-25